Maria Giovanna Dal Bello
8PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 29, 2023
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.Carlo Genova, Roberta Tasso, Alessandra Rosa
|Jul 27, 2022
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.Silvia Marconi, Michela Croce, Giovanna Chiorino
|Jul 02, 2021
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.Matteo Bauckneht, Carlo Genova, Giovanni Rossi
|Apr 03, 2021
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi
|May 06, 2020
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.Giovanni Rossi, Alessandro Russo, Marco Tagliamento
|Oct 05, 2019
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.Carlo Genova, Simona Boccardo, Marco Mora
Pageof 2
Frequent Collaborators
6 joint publications
Carlo Genova
6 joint publications
Marco Tagliamento
5 joint publications
Simona Coco
4 joint publications
Lodovica Zullo
4 joint publications
Giovanni Rossi
4 joint publications
Angela Alama
4 joint publications
Chiara Dellepiane
3 joint publications
Massimiliano Grassi
2 joint publications
Michela Croce
2 joint publications
Silvia Marconi
